Kepivance
Palifermin · Swedish Orphan Biovitrum AB (publ)
PRESCRIPTION ONLY (USA)Kepivance ingredients
| Active ingredient | Strength |
|---|---|
| Palifermin | 5.16 mg/1.2mL |
What Kepivance is used for
Kepivance is a specialist medicine (mucocutaneous epithelial cell growth factor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Kepivance
- Generic name
- Palifermin
- Made by
- Swedish Orphan Biovitrum AB (publ)
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous
- Drug class
- Mucocutaneous Epithelial Cell Growth Factor
- FDA approval
- Biologic licence (BLA) BLA125103
- On the US market since
- 2023
Official information
- Kepivance prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Palifermin)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Kepivance?
Kepivance (Palifermin) is a specialist medicine made by Swedish Orphan Biovitrum AB (publ), approved by the US FDA.
What are the ingredients of Kepivance?
Kepivance contains Palifermin (5.16 mg/1.2mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA